Koolwijk P, van Erck M G, de Vree W J, Vermeer M A, Weich H A, Hanemaaijer R, van Hinsbergh V W
Gaubius Laboratory TNO-PG, Leiden, The Netherlands.
J Cell Biol. 1996 Mar;132(6):1177-88. doi: 10.1083/jcb.132.6.1177.
In angiogenesis associated with tissue repair and disease, fibrin and inflammatory mediators are often involved. We have used three-dimensional fibrin matrices to investigate the humoral requirements of human microvascular endothelial cells (hMVEC) to form capillary-like tubular structures. bFGF and VEGF165 were unable to induce tubular structures by themselves. Simultaneous addition of one or both of these factors with TNFalpha induced outgrowth of tubules, the effect being the strongest when bFGF, VEGF165, and TNFalpha were added simultaneously. Exogenously added u-PA, but not its nonproteolytic amino-terminal fragment, could replace TNFalpha, suggesting that TNFalpha-induced u-PA synthesis was involved. Soluble u-PA receptor (u-PAR) or antibodies that inhibited u-PA activity prevented the formation of tubular structures by 59-99%. epsilon-ACA and trasylol which inhibit the formation and activity of plasmin reduced the extent of tube formation by 71-95%. TNFalpha or u-PA did not induce tubular structures without additional growth factors. bFGF and VEGF165 enhanced of the u-PAR by 72 and 46%, but TNFalpha itself also increased u-PAR in hMVEC by 30%. Induction of mitogenesis was not the major contribution of bFGF and VEGF165 because the cell number did not change significantly in the presence of TNFalpha, and tyrphostin A47, which inhibited mitosis completely, reduced the formation of tubular structures only by 28-36%. These data show that induction of cell-bound u-PA activity by the cytokine TNFalpha is required in addition to the angiogenic factors VEGF165 and/or bFGF to induce in vitro formation of capillary-like structures by hMVEC in fibrin matrices. These data may provide insight in the mechanism of angiogenesis as occurs in pathological conditions.
在与组织修复和疾病相关的血管生成过程中,纤维蛋白和炎症介质常常参与其中。我们利用三维纤维蛋白基质来研究人微血管内皮细胞(hMVEC)形成毛细血管样管状结构所需的体液条件。碱性成纤维细胞生长因子(bFGF)和血管内皮生长因子165(VEGF165)自身无法诱导管状结构的形成。将这两种因子中的一种或两种与肿瘤坏死因子α(TNFα)同时添加可诱导小管长出,当bFGF、VEGF165和TNFα同时添加时效果最强。外源性添加尿激酶型纤溶酶原激活物(u-PA)而非其无蛋白水解活性的氨基末端片段能够替代TNFα,这表明TNFα诱导的u-PA合成参与其中。可溶性尿激酶型纤溶酶原激活物受体(u-PAR)或抑制u-PA活性的抗体可使管状结构的形成减少59% - 99%。抑制纤溶酶形成和活性的ε-氨基己酸(ε-ACA)和抑肽酶可使管形成程度降低71% - 95%。若无额外的生长因子,TNFα或u-PA不会诱导管状结构的形成。bFGF和VEGF165使u-PAR分别增加72%和46%,但TNFα自身也可使hMVEC中的u-PAR增加30%。bFGF和VEGF165的主要作用并非诱导有丝分裂,因为在TNFα存在的情况下细胞数量没有显著变化,而完全抑制有丝分裂的 tyrphostin A47仅使管状结构的形成减少28% - 36%。这些数据表明,除血管生成因子VEGF165和/或bFGF外,细胞因子TNFα诱导细胞结合的u-PA活性对于在纤维蛋白基质中由hMVEC体外形成毛细血管样结构是必需的。这些数据可能为病理条件下发生的血管生成机制提供见解。